These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 24994626)

  • 21. Monsters at the patent office: the inconsistent conclusions of moral utility and the controversy of human cloning.
    Smith AR
    De Paul Law Rev; 2003; 53(1):159-203. PubMed ID: 15568254
    [No Abstract]   [Full Text] [Related]  

  • 22. Intellectual property. Supreme Court to review the scope of Monsanto's seed patents.
    Marshall E
    Science; 2013 Feb; 339(6120):639. PubMed ID: 23393238
    [No Abstract]   [Full Text] [Related]  

  • 23. US Patent Office issues guidelines on natural product patent eligibility.
    Harrison C
    Nat Rev Drug Discov; 2014 Apr; 13(4):250. PubMed ID: 24687057
    [No Abstract]   [Full Text] [Related]  

  • 24. Isolated DNA patent ban creates muddy waters for biomarkers and natural products.
    Harrison C
    Nat Rev Drug Discov; 2013 Aug; 12(8):570-1. PubMed ID: 23903213
    [No Abstract]   [Full Text] [Related]  

  • 25. US court bolsters biotech patent protection.
    Harrison C
    Nat Biotechnol; 2011 Aug; 29(8):672-3. PubMed ID: 21822224
    [No Abstract]   [Full Text] [Related]  

  • 26. Patent office decisions strengthened by Supreme Court.
    Baggot BX
    Nat Biotechnol; 1999 Nov; 17(11):1131-2. PubMed ID: 10545924
    [No Abstract]   [Full Text] [Related]  

  • 27. Biotech reels over patent ruling.
    Check-Hayden E
    Nature; 2014 Jul; 511(7508):138. PubMed ID: 25008505
    [No Abstract]   [Full Text] [Related]  

  • 28. The gene patenting controversy: a convergence of law, economic interests, and ethics.
    Kevles DJ; Berkowitz A
    Brooklyn Law Rev; 2001; 67(1):233-48. PubMed ID: 12645549
    [No Abstract]   [Full Text] [Related]  

  • 29. The Impact of Myriad on the Future Development and Commercialization of DNA-Based Therapies and Diagnostics.
    Wales M; Cartier E
    Cold Spring Harb Perspect Med; 2015 Sep; 5(12):. PubMed ID: 26337114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Who reads patents?
    Ouellette LL
    Nat Biotechnol; 2017 May; 35(5):421-424. PubMed ID: 28486445
    [No Abstract]   [Full Text] [Related]  

  • 31. Three recent US patent decisions.
    Kershen DL
    GM Crops Food; 2013; 4(3):122-5. PubMed ID: 23970059
    [No Abstract]   [Full Text] [Related]  

  • 32. Have you bargained away patent rights? Inventors and entrepreneurs need to consider a recent Supreme Court ruling in their patent strategies.
    Baggot B
    Nat Biotechnol; 1999 Mar; 17(3):297-8. PubMed ID: 10096300
    [No Abstract]   [Full Text] [Related]  

  • 33. U.S. intellectual property. Patent experts hope high court will clarify what's obvious.
    Kintisch E
    Science; 2006 Nov; 314(5803):1230-1. PubMed ID: 17124297
    [No Abstract]   [Full Text] [Related]  

  • 34. US personalized-medicine industry takes hit from Supreme Court.
    Ledford H
    Nature; 2016 Aug; 536(7617):382. PubMed ID: 27558042
    [No Abstract]   [Full Text] [Related]  

  • 35. Baseball bats and chocolate chip cookies: the judicial treatment of DNA in the myriad genetics litigation.
    Binnie I; Park-Thompson V
    Cold Spring Harb Perspect Med; 2014 Dec; 5(6):. PubMed ID: 25524722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patents. U.S. appeals court hears gene patent arguments.
    Marshall E
    Science; 2012 Jul; 337(6092):277-8. PubMed ID: 22822118
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of America Invents Act on Biotech Intellectual Property.
    Murphy A; Stramiello M; Stroud J; Lewis S; Irving T
    Cold Spring Harb Perspect Med; 2015 Apr; 5(9):a020784. PubMed ID: 25918182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of Myriad and Mayo: will advancements in the biological sciences be spurred or disincentivized? (Or was biotech patenting not complicated enough?).
    Gordon J
    Cold Spring Harb Perspect Med; 2014 Dec; 5(5):a020917. PubMed ID: 25502748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [U.S. Supreme Court ruling on patentability of genes].
    Darío Bergel S
    Rev Derecho Genoma Hum; 2013; (39):99-118. PubMed ID: 24868959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KSR v. Teleflex. Part 2: Impact of U.S Supreme Court Patent Law on Canadian and global systems-based innovation ecologies.
    Bouchard RA
    Health Law J; 2007; 15():247-94. PubMed ID: 19702185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.